Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis

International policy for treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR TB) relies largely on individual patient data (IPD) from observational studies of patients treated under routine conditions. We prepared guidance on which data to collect and what measures could improve cons...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Emerging infectious diseases Ročník 26; číslo 3
Hlavní autori:	Campbell, Jonathon R., Falzon, Dennis, Mirzayev, Fuad, Jaramillo, Ernesto, Migliori, Giovanni Battista, Mitnick, Carole D., Ndjeka, Norbert, Menzies, Dick
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Centers for Disease Control and Prevention 01.03.2020
Predmet:	Antitubercular Agents - pharmacology Antitubercular Agents - therapeutic use Clinical outcomes Clinical practice guidelines Data collection data collection standards Data dictionaries evidence-based medicine Humans Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis International policy Laboratories Meta-analysis multidrug resistance Mycobacterium tuberculosis - drug effects Observational studies Observational Studies as Topic - standards Online Report Patients Quality Improvement Rifampin - pharmacology Rifampin - therapeutic use therapy data collection Tuberculosis Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Pulmonary - drug therapy Womens health multidrug resistance data collection standards bacteria therapy data collection tuberculosis meta-analysis statistics and numerical data TB RR-TB antimicrobial resistance MDR TB practice guideline evidence-based medicine
ISSN:	1080-6040, 1080-6059, 1080-6059
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!